Case Study

Atrium Health’s Use of EndoTool IV Leads to $12 Million in Savings

Setting: Atrium Health Wake Forest Baptist, New Orleans, LA

The Customer

Atrium Health Wake Forest Baptist has successfully implemented EndoTool IV, a patient-specific insulin dosing system, to optimize the treatment of diabetic ketoacidosis (DKA), reducing hospital length of stay (LOS) and improving patient outcomes.

Challenges

Atrium Health aimed to:

Reduce hospital LOS caused by poor glycemic control.
Lower healthcare costs related to extended stays and hypoglycemia.
Enhance operational efficiency in glycemic management.

Key Results

Reduced Hospital LOS: EndoTool IV patients had a shorter average stay (3.95 days vs. 4.40 days), saving $12 million in total costs.
Improved Patient Safety: Fewer hypoglycemic events in the EndoTool IV group (10 events of hypoglycemia vs. 350 in the standard infusion group).
Operational Efficiency: Shorter stays allowed for better resource allocation and increased patient throughput.

Conclusion

The use of EndoTool IV has resulted in substantial cost savings, improved patient safety, and enhanced operational efficiency, solidifying its value in clinical practice.

Download

Quick navigation

References

Authors

M. McKnight, C. Price, C. Usoh, G. Russell, R. Bundy, J. Aloi

Source

Evaluation of Hospital Length of Stay in Patients with DKA Treated with EndoTool. Poster presented at: American Association of Clinical Endocrinology (AACE).

Year

2024

Download PDF